Pharmacological and Nonpharmacological Factors That Contribute Blood Pressure Control

Hypertension,Essential Clinical Trial

Official title:

Pharmacological and Nonpharmacological Factors That Contribute Blood Pressure Control

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05513430
• Other study ID #: 000001
• Status: Completed
• Start date: June 16, 2014
• Est. completion date: November 30, 2014

Study information

• Verified date: August 2022
• Source: Maltepe University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Study is an observational study among hypertensive patients

Description:

Objective: To investigate drug adherence and lifestyle behaviors affecting the blood pressure (BP) control among hypertensive patients that have uncontrolled and controlled BP.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 176
• Est. completion date: November 30, 2014
• Est. primary completion date: November 30, 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 74 Years

Eligibility

Patient inclusion criteria were as follows:

• aged between 38 and 74 years,
• hypertension diagnosis history of at least 6 months
• use of at least one antihypertensive medication. Exclusion Criteria: -not willing to join the clinical trial

Related Conditions & MeSH terms

• Essential Hypertension
• Hypertension,Essential

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Maltepe University	Istanbul University

References & Publications (2)

Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F; Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013 Jul;31(7):1281-357. doi: 10.1097/01.hjh.0000431740.32696.cc. — View Citation

Özünal, Z. G., Tahirbegolli, I. A., Baykal, M., Belen, A. T. E. S., Tahirbegolli, B., KILIÇ, Y., ... & Üresin, A. Y. (2019). The drug adherence and lifestyle factors that contribute to blood pressure control among hypertensive patients.

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	health related quality of life.	EQ-5D-3L turkish validation test	at the time of the beginning of the study
Primary	Age	years	at the time of the beginning of the study
Primary	Gender	Female/Male	at the time of the beginning of the study
Primary	BMI	(kg/m2)	at the time of the beginning of the study
Secondary	complementary and alternative medicine use	subjective reports from patients (yes/no)	at the time of the beginning of the study